800-437-4628 INFO@DMSHEALTH.COM
Request a Quote Customer Login
DMS Health
  • Home
  • Solutions
    • Interim Imaging
    • Mobile Imaging
    • Fixed Site Imaging
    • Accessories
  • Modalities
  • Blog
  • About
  • Careers
  • Contact
Select Page
Tauvid: New Alzheimer’s Focused PET Radiopharmaceutical

Tauvid: New Alzheimer’s Focused PET Radiopharmaceutical

by dmsAdmin | Jun 18, 2020 | Alzheimer’s, Radiopharmaceutical

Recently, the FDA provided approval for the use of two new PET radiopharmaceuticals, Cerianna and Tauvid. Cerianna is a molecular imaging agent indicated for use in PET imaging for the detection of estrogen receptor-positive lesions as an adjunct to biopsy in patients...
The Current Status of Alzheimer’s PET Imaging

The Current Status of Alzheimer’s PET Imaging

by dmsAdmin | May 12, 2020 | Alzheimer’s, PET/CT

Alzheimer’s disease is the sixth leading cause of death in the United States. Around one in three American seniors die from Alzheimer’s or another dementia, making it a bigger killer than breast and prostate cancer combined. In fact, deaths from Alzheimer’s disease...
dms health technologies logo
800-437-4628
INFO@DMSHEALTH.COM
Privacy Agreement
  • Home
  • Interim Imaging
  • Mobile Imaging
  • Fixed Site Imaging
  • Modalities
  • Accessories
  • Blog
  • About
  • Careers
  • Contact
  • Customer Portal
dms accreditation badges

DMS Health Technologies has earned the Joint Commission Goal Seal of Approval and ACR accreditation in multiple modalities — and we are an ISO-9001 certified mobile imaging provider.

All content Copyright © 2023, DMS Health. Knoxville web design and hosting by Slamdot.